| Literature DB >> 32610465 |
A M G C P Adikari1,2, Mahenderan Appukutty1,3, Garry Kuan4,5.
Abstract
Competitive football players who undergo strenuous training and frequent competitions are more vulnerable to psychological disorders. Probiotics are capable of reducing these psychological disorders. The present study aimed to determine the effect of daily probiotics supplementation on anxiety induced physiological parameters among competitive football players. The randomized, double-blinded, placebo-controlled trial was conducted on 20 male footballers who received either probiotics (Lactobacillus Casei Shirota strain 3 × 1010 colony forming units (CFU) or a placebo drink over eight weeks. Portable biofeedback devices were used to measure the electroencephalography, heart rate, and electrodermal responses along with cognitive tests at the baseline, week 4, and week 8. Data were statistically analyzed using mixed factorial ANOVA and results revealed that there is no significant difference between the probiotic and placebo groups for heart rate (61.90 bpm ± 5.84 vs. 67.67 bpm ± 8.42, p = 0.09) and electrodermal responses (0.27 µS ± 0.19 vs. 0.41 µS ± 0.12, p = 0.07) after eight weeks. Similarly, brain waves showed no significant changes during the study period except for the theta wave and delta wave at week 4 (p < 0.05). The cognitive test reaction time (digit vigilance test) showed significant improvement in the probiotic group compared to the placebo (p < 0.05). In conclusion, these findings suggest that daily probiotics supplementation may have the potential to modulate the brain waves namely, theta (relaxation) and delta (attention) for better training, brain function, and psychological improvement to exercise. Further research is needed to elucidate the mechanism of current findings.Entities:
Keywords: biofeedback; cognitive test; electroencephalography; football players; probiotics
Year: 2020 PMID: 32610465 PMCID: PMC7399934 DOI: 10.3390/nu12071920
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Physical characteristics measurements of the football players at the baseline.
| Parameter | Probiotic Group ( | Placebo Group ( |
|---|---|---|
| Age (years) | 19 ± 0.81 | 19 ± 0.66 |
| Training (years) | 7.9 ± 2.99 | 7.5 ± 2.67 |
| Height (cm) | 169.86 ± 5.74 | 169.05 ± 4.87 |
| Weight (kg) | 62.03 ± 5.31 | 65.82 ± 7.22 |
| BMI (kg/m2) | 21.59 ± 2.45 | 22.58 ± 2.20 |
Mean ± SD.
Between and within group interaction of the study variables.
| Time | Time*Group | |||||||
|---|---|---|---|---|---|---|---|---|
| Wilks’ Lambda |
| Partial Eta2 | Wilks’ Lambda |
| Partial Eta2 | |||
| Delta | 0.51 | 7.67 | 0.00 * | 0.48 | 0.83 | 1.62 | 0.22 | 0.16 |
| Theta | 0.93 | 0.52 | 0.60 | 0.06 | 0.96 | 0.27 | 0.76 | 0.03 |
| Alpha | 0.75 | 2.59 | 0.10 | 0.24 | 0.97 | 0.18 | 0.83 | 0.02 |
| Beta | 0.54 | 6.79 | 0.00 * | 0.45 | 0.97 | 0.23 | 0.79 | 0.02 |
| Gamma | 0.43 | 10.52 | 0.00 * | 0.56 | 0.90 | 0.81 | 0.46 | 0.09 |
| HR | 0.53 | 7.10 | 0.00 * | 0.47 | 0.97 | 0.24 | 0.78 | 0.03 |
| EDR | 0.25 | 23.39 | 0.00 * | 0.74 | 0.97 | 0.18 | 0.83 | 0.02 |
| DVT RT | 0.42 | 10.81 | 0.00 * | 0.57 | 0.88 | 1.05 | 0.37 | 0.11 |
| DVT AP | 0.98 | 0.12 | 0.88 | 0.01 | 0.91 | 0.76 | 0.48 | 0.08 |
Significant at p < 0.05 *; HR: Heart rate; EDR: Electrodermal responses; DVT RT: Digit vigilance test reaction time; DVT AP: Digit vigilance test accuracy percentage.
Pairwise comparison for the between group effect.
| Week 0 |
| Week 4 |
| Week 8 |
| ||||
|---|---|---|---|---|---|---|---|---|---|
| Probiotic | Placebo | Probiotic | Placebo | Probiotic | Placebo | ||||
| Alpha | 0.38 ± 0.12 | 0.45 ± 0.14 | 0.32 | 0.35 ± 0.08 | 0.38 ± 0.06 | 0.40 | 0.41 ± 0.13 | 0.47 ± 0.14 | 0.33 |
| Beta | 0.29 ± 0.18 | 0.34 ± 0.20 | 0.62 | 0.21 ± 0.11 | 0.29 ± 0.16 | 0.26 | 0.30 ± 0.11 | 0.41 ± 0.19 | 0.14 |
| Gamma | 0.04 ± 0.27 | 0.04 ± 0.21 | 0.98 | −0.11 ± 0.18 | −0.01 ± 0.19 | 0.27 | 0.09 ± 0.15 | 0.12 ± 0.24 | 0.69 |
| Theta | 0.27 ± 0.15 | 0.21 ± 0.20 | 0.50 | 0.33 ± 0.06 | 0.22 ± 0.13 | 0.02 * | 0.28 ± 0.16 | 0.21 ± 0.21 | 0.43 |
| Delta | 0.60 ± 0.16 | 0.60 ± 0.25 | 0.95 | 0.80 ± 0.08 | 0.64 ± 0.21 | 0.04 * | 0.46 ± 0.17 | 0.44 ± 0.25 | 0.80 |
| EDR | 1.12 ± 0.57 | 1.15 ± 0.40 | 0.93 | 0.36 ± 0.32 | 0.53 ± 0.23 | 0.20 | 0.27 ± 0.19 | 0.41 ± 0.12 | 0.07 |
| HR | 76.00 ± 16.14 | 77.78 ± 12.23 | 0.79 | 65.30 ± 8.93 | 69.00 ± 9.18 | 0.38 | 61.90 ± 5.84 | 67.67 ± 8.42 | 0.09 |
| DVT RT | 3.66 ± 0.83 | 3.69 ± 0.56 | 0.93 | 2.80 ± 0.47 | 3.18 ± 0.65 | 0.16 | 2.71 ± 0.41 | 3.24 ± 0.59 | 0.03* |
| DVT AP | 97.00 ± 2.98 | 96.55 ± 2.00 | 0.71 | 97.60 ± 1.65 | 96.00 ± 3.04 | 0.16 | 98.10 ± 1.10 | 96.22 ± 3.59 | 0.16 |
Significant at p < 0.05 *; HR: Heart rate; EDR: Electrodermal responses; DVT RT: Digit vigilance test reaction time; DVT AP; Digit vigilance test accuracy percentage.
Figure 1(a) Delta absolute power and (b) theta absolute power deviation during the intervention. (PG = Probiotic Group, PL = Placebo Group).
Figure 2(a) Heart rate response deviation throughout the study; (b) electrodermal response deviation throughout the study (PG = Probiotic Group, PL = Placebo Group).
Figure 3(a) DVT reaction time during the study period; (b) DVT accuracy percentage during the study period (PG = Probiotic Group, PL = Placebo Group).